SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Investment Ideas Served Daily By People You Trust
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

7 pts

Opinion on  Amylin Pharmaceuticals Inc (AMLN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Amylin Pharmaceuticals Inc.

Jun 22, 2008 09:11 AM UTC
Foto
Return Risk
-25.96% HIGH
Principal

Fundamental Analysis  

Amylin and Mallinckrodt amended their manufacturing agreement dated October 1, 2003, pursuant to which Mallinckrodt manufactures and supplies to Amylin bulk exenatide, the active ingredient in BYETTA injection. Under the terms of the Amendment, the termination date of agreement has been extended for a period of four years to September 30, 2012.


AMLN:  This call was made on 06/22/08 @ $26.06
Rating:   Positive   $26.06 (06/22/08)
Gain/Loss:   -54.11% in 199 days
Target:   $62.00 (+137.91%) in > one year
Allocation:   0.3% of portfolio


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

Who voted on this idea?
Sad
Kenny Shen 58% 08/06/2008



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 16.93 +37.62% 76
2 15.63 +15.87% 10
3 14.29 +16.71% 41
4 14.07 +22.85% 16
5 12.69 +28.47% 183


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Amylin Pharmaceuticals Inc (AMLN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
57.0%
Top:
100.0%




Latest Picks by Marian Filo
Symbol SP Sentiment Rating Return Since
RPID N/A Positive +7.14% 01/07/09
VCRT N/A Positive -6.67% 01/07/09
IDEV N/A Positive -0.75% 01/07/09
AERS N/A Positive +0.00% 01/07/09
BR Positive +6.94% 12/22/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch